On October 24, 2018, By-health and Bioiberica S.A.U. (hereinafter referred to as "Bioiberica") signed an innovation strategic cooperation agreement (hereinafter referred to as "the agreement") to establish cooperative relation in promoting two raw materials’ ("b - 2 cool, the degeneration type II collagen" and "Mobilee Comb extract") product development and market application in China and Australia, developing joint maintenance new product formula, implementing joint health research such as biomarkers and mechanism, and new ingredients from animals. Bioiberica is a biotech company specialized in the identification and extraction of bio molecule with high biological and therapeutic value from animal sources.
By-health is committed to the wide and in-depth promotion of its main popular brand "By-health", and the company is also actively expanding bone health and other segmentation. Through international cooperation in the form of a number of scientific researches including conducting terminal functional health food products research and development based on mature raw materials, joint health and functional new materials research and product development, the innovative strategic partnership with Bioiberica is the active practice of the company’s key item strategy as well as the exploration in the new field of joint-health.
- White Paper on Bone and Joint Health of Chinese Consumers 2020
- Yili Dairy launched high-protein yogurt, focusing on sport people
- Sinopharm Xingsha launched the Japan's Champion probiotics
- China has introduced its first policy to support the industrial hemp industry
- Beyond Meat became the first overseas Artificial Meat company to set up a factory in China
- Nongfu Spring's market value exceeded HK $370 billion on its first day
- German infant nutrition brand Amykon launched two probiotics in China
- The revenue of Besunyoung in the first half year is about 610 million yuan
- Jellly candy and powder included in the health food filing dosage form in China
- H&H Group net profit increased by 9% for the first half of year

